Robinson Chandler
CIK 1727334
Transactions on file
23
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-20 | 2026-10-20 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 597 | $55.3K | -21.5% | open → |
| 2026-10-02 | 2026-09-30 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 4,344 | $346.1K | -8.8% | open → |
| 2026-10-02 | 2026-09-30 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 9,801 | $0.00 | — | open → |
| 2026-09-29 | 2026-09-24 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Sale | 600 | $53.9K | -19.1% | open → |
| 2026-09-29 | 2026-09-24 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Sale | 8,368 | $744.5K | -18.3% | open → |
| 2026-09-29 | 2026-09-24 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Sale | 9,638 | $847.8K | -17.4% | open → |
| 2026-09-29 | 2026-09-24 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Sale | 10,450 | $910.7K | -16.6% | open → |
| 2026-09-29 | 2026-09-24 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 15,000 | $210.0K | +419.1% | open → |
| 2026-09-29 | 2026-09-24 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 14,056 | $421.7K | +142.3% | open → |
| 2025-01-02 | 2024-12-31 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 2,209 | $48.6K | +230.4% | open → |
| 2025-01-02 | 2024-12-31 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 4,895 | — | — | open → |
| 2025-03-07 | 2025-03-04 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 1,759 | $55.8K | +129.3% | open → |
| 2025-03-07 | 2025-03-04 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 6,002 | — | — | open → |
| 2025-04-02 | 2025-03-31 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 1,204 | $43.8K | +99.6% | open → |
| 2025-04-02 | 2025-03-31 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 4,106 | — | — | open → |
| 2025-04-04 | 2025-04-02 | MNPR Monopar Therapeutics | Other | Sale | 33,334 | $1.17M | +107.7% | open → |
| 2025-10-02 | 2025-09-30 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 2,646 | $216.1K | -11.0% | open → |
| 2025-10-02 | 2025-09-30 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 8,726 | $0.00 | — | open → |
| 2025-07-02 | 2025-06-30 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Tax | 5,865 | $209.8K | +103.1% | open → |
| 2025-07-02 | 2025-06-30 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Exer. | 13,344 | — | — | open → |
| 2025-07-16 | 2025-07-14 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | Sale | 16,800 | $672.0K | +81.7% | open → |
| 2025-07-16 | 2025-07-14 | MNPR Monopar Therapeutics | OfficerDirector Chief Executive Officer | X | 16,800 | $168.00 | +726700.0% | open → |
| 2025-09-26 | 2025-09-24 | MNPR Monopar Therapeutics | Other | Sale | 550,229 | $35.00M | +14.3% | open → |
